A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate two different dosing regimens of LY2334737 in
participants with cancer that is advanced and/or has spread to other parts of the body.
Information about side effects will be collected.